Literature DB >> 3705195

Cardiac arrhythmia: possible complication from treatment with cisplatin.

L Canobbio, T Fassio, G Gasparini, G Caruso, L Barzan, R Comoretto, F Brema, F Villani.   

Abstract

Cardiotoxicity is rarely observed during cisplatin chemotherapy. A possible synergistic toxic effect of cisplatin with etoposide on cardiac electrical activity is discussed. A case of a 60-year-old woman with squamous cell lung carcinoma who developed paroxysmal supraventricular tachycardia during cisplatin chemotherapy is reported. The potential cardiotoxicity should be considered when cisplatin is combined with other cardiotoxic agents or used in patients with cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3705195     DOI: 10.1177/030089168607200215

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

Review 1.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

2.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

Authors:  Joy M Fulbright
Journal:  Cardiol Res Pract       Date:  2011-05-23       Impact factor: 1.866

4.  Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.

Authors:  Harshal Nemade; Umesh Chaudhari; Aviseka Acharya; Jürgen Hescheler; Jan Georg Hengstler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2018-02-03       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.